Synthesis of 4-(thiazol-2-ylamino)-benzenesulfonamides with carbonic anhydrase I, II and IX inhibitory activity and cytotoxic effects against breast cancer cell lines

被引：52
|
作者：
Gawad, Nagwa M. Abdel [1 ]
Amin, Noha H. [2 ]
Elsaadi, Mohammed T. [2 ]
Mohamed, Fatma M. M. [2 ]
Angeli, Andrea [3 ]
De Luca, Viviana [4 ]
Capasso, Clemente [4 ]
Supuran, Claudiu T. [3 ]
机构：
[1] Cairo Univ, Fac Pharm, Dept Pharmaceut Chem, Cairo 11562, Egypt
[2] Beni Suef Univ, Dept Med Chem, Fac Pharm, Bani Suwayf 62514, Egypt
[3] Univ Florence, Dipartimento Neurofarba, Sez Sci Farmaceut & Nutraceut, Via U Schiff 6, I-50019 Florence, Italy
[4] CNR, Ist Biosci & Biorisorse, Via Pietro Castellino 81, I-80125 Naples, Italy
来源：
BIOORGANIC & MEDICINAL CHEMISTRY | 2016年 / 24卷 / 13期
关键词：
Carbonic anhydrase; Inhibitor; Sulfonamide; Antitumor; Cytotoxic agent; RAY CRYSTAL-STRUCTURE; HUMAN ISOFORM-II; ISOZYME-II; SELECTIVE INHIBITORS; THERAPEUTIC APPLICATIONS; SULFONAMIDE DERIVATIVES; XII INHIBITORS; BINDING; ANTICANCER; HYPOXIA;
D O I：
10.1016/j.bmc.2016.05.016
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
A series of 4-(thiazol-2-ylamino)-benzenesulfonamides was synthesized and screened for their carbonic anhydrase (CA, EC 4.2.1.1) inhibitory and cytotoxic activity on human breast cancer cell line MCF-7. Human (h) CA isoforms I, II and IX were included in the study. The new sulfonamides showed excellent inhibition of all three isoforms, with K(I)s in the range of 0.84-702 nM against hCA I, of 0.41-288 nM against hCA II and of 5.6-29.2 against the tumor-associated hCA IX, a validated anti-tumor target, with a sulfonamide (SLC-0111) in Phase I clinical trials for the treatment of hypoxic, metastatic solid tumors overexpressing CA IX. The new compounds showed micromolar inhibition of growth efficacy against breast cancer MCF-7 cell lines. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码：3043 / 3051
页数：9
相关论文
共 43 条
  • [31] Synthesis of 4-[2-(3,4-dimethoxybenzyl)cyclopentyl]-1,2-dimethoxybenzene Derivatives and Evaluations of Their Carbonic Anhydrase Isoenzymes Inhibitory Effects
    Artunc, Tekin
    Cetinkaya, Yasin
    Gocer, Hulya
    Gulcin, Ilhami
    Menzek, Abdullah
    Sahin, Ertan
    Supuran, Claudiu T.
    CHEMICAL BIOLOGY & DRUG DESIGN, 2016, 87 (04) : 594 - 607
  • [32] Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studies
    Milite, Ciro
    Amendola, Giorgio
    Nocentini, Alessio
    Bua, Silvia
    Cipriano, Alessandra
    Barresi, Elisabetta
    Feoli, Alessandra
    Novellino, Ettore
    Da Settimo, Federico
    Supuran, Claudiu T.
    Castellano, Sabrina
    Cosconati, Sandro
    Taliani, Sabrina
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2019, 34 (01) : 1697 - 1710
  • [33] The synthesis of (Z)-4-oxo-4-(arylamino)but-2-enoic acids derivatives and determination of their inhibition properties against human carbonic anhydrase I and II isoenzymes
    Oktay, Koray
    Kose, Leyla Polat
    Sendil, Kivilcim
    Gultekin, Mehmet Serdar
    Gulcin, Ilhami
    Supuran, Claudiu T.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2016, 31 (06) : 939 - 945
  • [34] Synthesis of novel 4-functionalized 1,5-diaryl-1,2,3-triazoles containing benzenesulfonamide moiety as carbonic anhydrase I, II, IV and IX inhibitors
    Vats, Lalit
    Sharma, Vikas
    Angeli, Andrea
    Kumar, Rajiv
    Supuran, Claudiu T.
    Sharma, Pawan K.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 150 : 678 - 686
  • [35] Synthesis and carbonic anhydrase I, II, IX and XII inhibition studies of 4-N,N-disubstituted sulfanilamides incorporating 4,4,4-trifluoro-3-oxo-but-1-enyl, phenacylthiourea and imidazol-2(3H)-one/thione moieties
    Congiu, Cenzo
    Onnis, Valentina
    Balboni, Gianfranco
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (07) : 1776 - 1779
  • [36] Synthesis of bulky-tailed sulfonamides incorporating pyrido[2,3-d] [1,2,11]triazolo[4,3-a]pyrimidin-1(5H)-yl) moieties and evaluation of their carbonic anhydrases I, II, IV and IX inhibitory effects
    Fares, Mohamed
    Eladwy, Radwa A.
    Nocentini, Alessio
    Abd El Hadi, Soha R.
    Ghabbour, Hazem A.
    Abdel-Megeed, Ashraf
    Eldehna, Wagdy M.
    Abdel-Aziz, Hatem A.
    Supuran, Claudiu T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (07) : 2210 - 2217
  • [37] Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N′-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII
    Zolnowska, Beata
    Slawinski, Jaroslaw
    Pogorzelska, Aneta
    Chojnacki, Jaroslaw
    Vullo, Daniela
    Supuran, Claudiu T.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 71 : 135 - 147
  • [38] Carbonic anhydrase inhibitors. Regioselective synthesis of novel series 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII
    Brzozowski, Zdzislaw
    Slawinski, Jaroslaw
    Vullo, Daniela
    Supuran, Claudiu T.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 56 : 282 - 291
  • [39] Substituted 6-amino-4H-[1,2]dithiolo[4,3-b]pyrrol-5-ones:: Synthesis, structure-activity relationships, and cytotoxic activity on selected human cancer cell lines
    Li, Bin
    Lyle, Michael P. A.
    Chen, Genhui
    Li, Jason
    Hu, Kaiji
    Tang, Liren
    Alaoui-Jamali, Moulay A.
    Webster, John
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (13) : 4601 - 4608
  • [40] Discovery of N-(4-(3-(2-Aminopyrimidin-4-yl)pyridin-2-yloxy)phenyl)-4-(4-methylthiophen-2-yl)phthalazin-1-amine (AMG 900), A Highly Selective, Orally Bioavailable Inhibitor of Aurora Kinases with Activity against Multidrug-Resistant Cancer Cell Lines
    Geuns-Meyer, Stephanie
    Cee, Victor J.
    Deak, Holly L.
    Du, Bingfan
    Hodous, Brian L.
    Hanh Nho Nguyen
    Olivieri, Philip R.
    Schenkel, Laurie B.
    Vaida, Karina R.
    Andrews, Paul
    Bak, Annette
    Be, Xuhai
    Beltran, Pedro J.
    Bush, Tammy L.
    Chaves, Mary K.
    Chung, Grace
    Dai, Yang
    Eden, Patrick
    Hanested, Kelly
    Huang, Liyue
    Lin, Min-Hwa Jasmin
    Tang, Jin
    Ziegler, Beth
    Radinsky, Robert
    Kendall, Richard
    Patel, Vinod F.
    Payton, Marc
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (13) : 5189 - 5207
12345